Loading quotes...

Forecast

Buy
  6
Hold
  2
Sell
  0

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, Chromadex had revenue of €26.1m and net profit of €843.79k
(EUR) June 2026
YoY
Revenue 26.1m -
Gross profit 16.92m 1.38%
Net profit 843.79k 72.44%
EBITDA 1.19m 64.29%

Fundamentals

Metric Value
Market capitalization
€546.06m
Number of shares
77.75m
52-week high/low
€8.19 - €2.06
Dividends No
Beta
2.21
P/E ratio
13.00
PEG ratio
-0.75
P/B ratio
2.43
P/S ratio
1.55

Company profile

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.

Name
Chromadex
CEO
Frank Louis Jaksch Jr.
Headquarters Los Angeles, ca
USA
Website
Sector
Consumer Staples
Industry
Personal Care Products
IPO
25/06/2008
Employees 104

Ticker symbols

Exchange Symbol
NASDAQ
CDXC
Frankfurt
OCD1.F
Düsseldorf
OCD1.DU
München
OCD1.MU
NASDAQ
NAGE
🍪

Parqet  uses cookies. Learn more